Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors

Clinical trial NCT02629926 · UNKNOWN

Trial details

NCT number: NCT02629926
Sponsor: The Leeds Teaching Hospitals NHS Trust
Status: UNKNOWN
Study type: OBSERVATIONAL

Metabolic Diseases Cancer

Start date: 2010-10-01
Primary completion: 2015-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.